MedTrace Logo

Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers

NCT00716209 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2014-03-05

No results posted yet for this study

Summary

The proposal seeks to establish:

* A comprehensive compilation (database) of clinical information comprising clinical, histopathological, treatment and follow-up characteristics of past and future gastrointestinal cancer (GIC) cases in Singapore that can be shared by investigators. The characteristics will include clinical (eg age, sex, stage), histopathological (eg. grade, type), treatment (eg. treatment status, regimens) and outcome data (eg. survival, toxicity) from medical records.
* A collection (bank) of corresponding frozen and fixed tissue, blood and processed samples (enriched blood mononuclear cells, protein, RNA, DNA, tissue arrays) in Singapore that can be shared by the investigators.
* A gastrointestinal cancer co-operative group (GCCG) of clinicians and scientists researching prognostic and predictive markers in GIC, which will benefit from the multi-disciplinary knowledge, information and samples of its members.
* To characterise genetic polymorphisms related to Gastrointestinal cancer chemotherapy treatment in controls (healthy volunteers)

Conditions

Sponsors & Collaborators

  • Haematology-Oncology

    lead OTHER

Principal Investigators

  • Ross Andrew Soo, MBBS · National University Hospital, Singapore

  • Alex Chang · Johns Hopkins Singapore International Medical Centre

  • Chung Yip Chan · Tan Tock Seng Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00716209 on ClinicalTrials.gov